REED JOHN C 4
4 · JOHNSON & JOHNSON · Filed Feb 18, 2025
Insider Transaction Report
Form 4
REED JOHN C
EVP, Innovative Medicine, R&D
Transactions
- Exercise/Conversion
Common Stock
2025-02-15+1,350→ 15,927 total - Tax Payment
Common Stock
2025-02-18$156.15/sh−385$60,118→ 15,542 total - Exercise/Conversion
Restricted Share Units
2025-02-15−1,350→ 2,698 total→ Common Stock (1,350 underlying)
Footnotes (3)
- [F1]Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.
- [F2]Shares withheld for payment of taxes upon vesting of RSUs.
- [F3]Each RSU represents a contingent right to receive one share of Company Common Stock.